Where does Neuronano AB rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Neuronano AB ranks #16,231 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Neuronano AB hold?

Neuronano AB holds 18 US utility patents granted between 2015 and 2025, spanning 13 technology areas.

What is Neuronano AB's Innovation Score?

Neuronano AB has an Innovation Score of 47.6 out of 100 (top 18% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Neuronano AB focus on?

Neuronano AB's top technology area is A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy) with 18 patents, ranking #202 of 1,943 assignees active in that subclass. Grants appear in 13 CPC subclasses total.

Is Neuronano AB's patent grant rate increasing or decreasing?

Neuronano AB's recent grant velocity is +43% compared to the prior five-year period (grant years, not application filing dates). The company is maintaining or growing its granted-patent output.

What does claim depth mean for Neuronano AB's patents?

Neuronano AB's patents average 23.4 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Neuronano AB patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Neuronano AB

USPTO PatentsView assignee record - 18 granted patents across 13 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Neuronano ranks #16,231 of 49,997 tracked US assignees by granted-patent volume, with 18 patents across 13 technology areas.

#16,231
of 49,997 US assignees by volume: Top 18%
by Innovation Score (47.6/100): 23.4
avg claims per patent: +43%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R16231 · Foreign Corporation #16,231 · 18 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-DENSE · TYPE-FRNCORP · VEL-UP · BOOK-FULL

GRANTS-MICRO 18 grants
MID-PACK #16,231/49,997
PHOTO-FINISH National Synchrotron…
CPC-FOCUS A61N · 13 areas
INNOV-PAR 47.6/100
CLAIMS-DENSE 23.4 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-UP +43% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: National Synchrotron Radiation Research Center (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Neuronano’s 47.6 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 10.2 pts (21%) Velocity 10.7 pts (22%) Breadth 12.7 pts (27%) Claim depth 14.0 pts (29%)

Qualcomm Incorporated · highest

85
Neuronano AB · this assignee

48
3D Lighting… · lowest

7

What this shows Neuronano's Innovation Score is 47.6/100 (top 18% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Neuronano?

Each dot is one of Neuronano’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Neuronano’s own 23.4 claims/patent is ABOVE the 8.3 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Neuronano vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Neuronano's grants concentrate

Neuronano AB is a focused PatentsView assignee: 13 CPC subclasses with 100% of grants classified under A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy). Peak complete grant year is 2023 (5 grants) versus a trough of 1 in 2015. By volume, Neuronano sits between National Synchrotron Radiation Research Center and Nippon Valqua Industries, Ltd..

Neuronano's three-year grant acceleration

Neuronano AB shows 8 grants in 2022–2024 against only 5 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

National Synchrot…

18
Neatfreak Group

18
NEC Network and S…

18
Neubrex

18
Neutrace

18
Ningbo Weie Techn…

18
Nippon Kodoshi

18
Nippon Valqua Ind…

18
Neuronano AB ◀

18

What this shows Neuronano holds 18 patents at rank #16,218, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Neuronano

By rank, the assignees closest to #16,218 in granted patent volume.

Leaders in A61N (Electrotherapy)

Other assignees with the most granted patents in Neuronano's primary technology class.

Neuronano's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

48 Top 18% higher than 82% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Neuronano AB patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	1	5.6%
2017	2	11.1%
2018	1	5.6%
2019	3	16.7%
2021	2	11.1%
2023	5	27.8%
2024	3	16.7%
2025partial year	1	5.6%

Which technologies does Neuronano AB patent most?

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy 18

A61B - DIAGNOSIS; SURGERY; Identification 16

A61L - Methods OR Apparatus FOR Sterilising Materials OR Objects IN GENERAL; Disinfection, Sterilisation OR Deodorisation OF AIR; Chemical Aspects OF Bandages, Dressings, Absorbent Pads OR Surgical ARTICLES; Materials FOR Bandages, Dressings, Absorbent Pads OR Surgical Articles 6

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 3

A61G - Transport, Personal Conveyances, OR Accommodation Specially Adapted FOR Patients OR Disabled Persons ; Operating Tables OR CHAIRS; Chairs FOR DENTISTRY; Funeral Devices 1

A61F - Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs 1

Y02E - Reduction OF Greenhouse GAS [GHG] Emissions, Related TO Energy Generation, Transmission OR Distribution 1

H10K - Organic Electric Solid-state Devices 1

H10F - Inorganic Semiconductor Devices Sensitive TO Infrared Radiation, Light, Electromagnetic Radiation OF Shorter Wavelength OR Corpuscular Radiation 1

B82Y - Specific Uses OR Applications OF NANOSTRUCTURES; Measurement OR Analysis OF NANOSTRUCTURES; Manufacture OR Treatment OF Nanostructures 1

G16H - Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data 1

D10B - Indexing Scheme Associated With Sublasses OF Section D, Relating TO Textiles 1

D04H - Making Textile Fabrics, e.g. From Fibres OR Filamentary Material ; Fabrics Made BY Such Processes OR Apparatus, e.g. Felts, Non-woven FABRICS; COTTON-WOOL; Wadding ; ; Non-woven Fabrics From Staple Fibres, Filaments OR Yarns, Bonded With AT Least ONE Web-like Material During Their Consolidation 1

Top 13 of 13 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Neuronano AB's patent record in context - here's where to go next.

Neuronano AB's lead technology class is A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy), 100% of its portfolio - see every assignee active in that class. Explore A61N
Ranked #16,231 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Neuronano AB against National Synchrotron Radiation Research Center, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 47.6/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.